Invention Grant
US08809579B2 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
有权
胰高血糖素受体拮抗剂化合物，含有这些化合物的组合物和使用方法
- Patent Title: Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
- Patent Title (中): 胰高血糖素受体拮抗剂化合物，含有这些化合物的组合物和使用方法
-
Application No.: US13148577Application Date: 2010-02-03
-
Publication No.: US08809579B2Publication Date: 2014-08-19
- Inventor: Roman Kats-Kagan , Christian P. Stevenson , Xibin Liao , Qinghong Fu , Emma R. Parmee , Songnian Lin
- Applicant: Roman Kats-Kagan , Christian P. Stevenson , Xibin Liao , Qinghong Fu , Emma R. Parmee , Songnian Lin
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Anna L. Cocuzzo; Catherine D. Fitch
- International Application: PCT/US2010/022963 WO 20100203
- International Announcement: WO2010/098948 WO 20100902
- Main IPC: C07C229/00
- IPC: C07C229/00 ; A01N43/04
Abstract:
Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.
Public/Granted literature
- US20110312911A1 GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE Public/Granted day:2011-12-22
Information query
